Clinical Trial Update: Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of lapatinib ditosylate and capecitabine in patients with metastatic pancreatic cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lapatinib Ditosylate (lapatinib ditosylate)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED